Subscribe to Obesity Panacea
Subscribe to Obesity Panacea
Subscribe to Obesity Panacea by mail

A CB1 update

Friday, November 07, 2008 Posted by Travis Saunders
There have been dramatic developments this week for a class of weight loss drugs known as CB1 antagonists, which Peter brought up earlier this week. Dr Arya Sharma has an excellent post on his blog describing the risks and benefits of this class of medications, and what we can expect now that they are no longer available. A great read for anyone who is interested in the medical treatment of obesity.

Enjoyed this story? Share it with your friends by clicking the buttons below!

Twitter Facebook Digg It! Stumble Delicious Technorati

To get future posts delivered directly to your email inbox or to your RSS reader, be sure to subscribe to Obesity Panacea.
You can leave a response, or trackback from your own site.

0 Response to "A CB1 update"

Blog Archive

Recent Posts

Peter's Travel Adventures on PhD Nomads

About Us

We are PhD students in the School of Kinesiology and Health Studies at Queen's University in Kingston, Ontario. Our research focuses on the relationships between obesity, physical activity, and health risk. This blog is our attempt to consider the many "cures" for obesity that we read about on a daily basis. Enjoy.

Disclaimer

The opinions expressed here belong only to Peter and Travis and do not reflect the views of any organization. Any medical discussion on this page is intended to be of a general nature only. This page is not designed to give specific medical advice. If you have a medical problem you should consult your own physician for advice specific to your own situation.

Donate To Obesity Panacea

Visitors